CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis.

Document type:: Journal Article
Author(s):: Thomas, Jenny; Wang, Rosi; Batra, Richa; Böhner, Alexander; Garzorz-Stark, Natalie; Eberlein, Bernadette; Theis, Fabian; Biedermann, Tilo; Schmidt-Weber, Carsten; Zink, Alexander; Eyerich, Kilian; Eyerich, Stefanie
Title:: CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis.
Journal title abbreviation:: J Invest Dermatol
Year:: 2021
Journal volume:: 141
Journal issue:: 3
Pages contribution:: 681-685.e6
Fulltext / DOI:: doi:10.1016/j.jid.2020.05.122
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/32949565
Print-ISSN:: 0022-202X
TUM Institution:: Klinik und Poliklinik für Dermatologie und Allergologie; Molekulare Allergologie (Prof. Schmidt-Weber); Professur für Experimentelle Dermato-Immunologie (Prof. Eyerich)
BibTeX